Peer-reviewed veterinary case report
Prevention and treatment of atopic dermatitis in dogs 2008-2011
By Olivry, Thierry & Bizikova, Petra·Published in Veterinary dermatology·2013·Department of Clinical Sciences and Center for Comparative Medicine and Translational Research, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update.
- Species:
- dog
Plain-English summary
A review of studies on treating skin allergies in dogs found that oral glucocorticoids and ciclosporin are effective options for managing atopic dermatitis (AD), which causes itching and skin lesions. The review included 21 trials and highlighted that a topical glucocorticoid spray with hydrocortisone aceponate also showed moderate effectiveness. Other treatments, like injectable interferons and certain diets, had less reliable results. Overall, glucocorticoids and ciclosporin are the most recommended treatments for dogs suffering from AD, helping to reduce symptoms and improve skin health.
People also search for: dog skin allergies treatment · atopic dermatitis in dogs · glucocorticoids for dog itching · ciclosporin for dog skin problems
Abstract
BACKGROUND: The management of atopic dermatitis (AD) in dogs relies mainly on the use of interventions to reduce pruritus and skin lesions. OBJECTIVES: To provide a critical analysis of recent clinical trials reporting the efficacy and safety of interventions for canine AD. METHODS: Systematic review of randomized controlled trials (RCTs) published, presented or completed between 2008 and 2011, which enrolled dogs with AD. The search was done using electronic databases, reviewing published meeting abstracts and sending queries to professional email lists. Trials reporting the efficacy of interventions aimed at treating, preventing or reducing glucocorticoid usage in atopic dogs were selected. RESULTS: Twenty-one RCTs were included. We found further moderate-quality evidence of efficacy and safety of oral glucocorticoids and ciclosporin for treatment of canine AD. There was additional moderate-quality evidence of the efficacy of a topical glucocorticoid spray containing hydrocortisone aceponate. Low-quality evidence was found for the efficacy and safety of injectable recombinant interferons, a budesonide leave-on conditioner, a ciclosporin topical nano-emulsion and oral fexofenadine. There is low-quality evidence of efficacy of oral masitinib, with a need for monitoring for protein-losing nephropathy. Finally, we uncovered low-quality evidence of efficacy of a commercial diet as a glucocorticoid-sparing intervention and of a glucocorticoid spray as a flare-delaying measure. Very low-quality evidence was found for the efficacy of other interventions. CONCLUSIONS AND CLINICAL IMPORTANCE: Topical or oral glucocorticoids and oral ciclosporin remain the interventions with highest evidence for efficacy and relative safety for treatment of canine AD.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23331686/